InvestorsHub Logo
Followers 57
Posts 11397
Boards Moderated 0
Alias Born 02/09/2009

Re: None

Monday, 04/21/2014 5:18:33 PM

Monday, April 21, 2014 5:18:33 PM

Post# of 30990
Permission to file an NDA can move a stock price

Sarepta Therapeutics (Nasdaq:SRPT) is up 62% this morning on news that the FDA is going to allow the company to file a new drug application for a Duchenne Muscular Dystrophy (DMD) treatment...

-The Daily Reckoning

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.